Filter Results
Clinical Studies
Results filtered:Study status:
Open
Closed for Enrollment
Open
-
MC220712 Phase 0/I Clinical Trial of the ATM-Inhibitor WSD0628 in Combination with Radiation Therapy for Recurrent Brain Tumors
Rochester, Minn.
The purpose of this study is to test WSD0628 in combination with radiation therapy for recurrent brain tumors.
-
Stereotactic Accelerated Radiotherapy in GlioblastomA (SAGA)
Rochester, Minn.,
Mankato, Minn.,
La Crosse, Wis.,
Jacksonville, Fla.,
Eau Claire, Wis.,
Scottsdale/Phoenix, Ariz.,
Albert Lea, Minn.
The purpose of this study is to demonstrate non-inferior 12-month overall survival of patients with GlioblastomA (GBM) treated with dose escalated hypofractionated radiotherapy compared to standard of care. Also, to demonstrate the safety and favorable quality of life via physician-reported G3+ toxicitycompare if SBRT is non-inferior to standard of care on the proportion of overall survival of patients with glioblastoma 12 months after randomization.
Closed for Enrollment
-
SBRT with Immunotherapy for Mesothelioma
Rochester, Minn.
The purpose of this study is to evaluate whether adding stereotactic body radiation therapy (SBRT) to immunotherapy as part of second line treatment for mesothelioma will improve the modest response rate of immunotherapy alone, provide local control/cytoreduction to sites of gross disease, and decrease symptomatic burden while improving outcomes.
.